Prescription drug · BLA
Vectibix (Panitumumab) NDC 55513-954
Panitumumab 100 mg/5mL · Solution · Intravenous · Amgen, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55513-954-01 | 55513095401 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 10, 2006 | |
| 55513-954-21 | 55513095421 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-21) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vectibix
- Generic name (nonproprietary)
- panitumumab
- Active ingredients
- Panitumumab — 100 mg/5mL
- Dosage form
- Solution
- Route
- Intravenous
- Labeler
- Amgen, IncNDC labeler code 55513
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125147
- Marketing start
- Listing expires
- Other FDA classes
- Monoclonal (Chemical structure)HER1 Antagonists (Mechanism)
- Identifiers
- Product ID 55513-954_a46c4cd4-282a-4920-9372-759f83c286faSPL ID a46c4cd4-282a-4920-9372-759f83c286faSPL set ID e0fa4bca-f245-4d92-ae29-b0c630a315c2RxCUI 1657703, 1657705, 1657722, 1657723UNII 6A901E312A
- Pharmacologic class
- Epidermal Growth Factor Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455513095401followed by a unit qualifier and the quantityPackage 55513-0954-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Vectibix is an epidermal growth factor receptor (EGFR) antagonist indicated for the treatment of: Adult patients with wild-type RAS (defined as wild-type in both KRAS and NRAS as determined by an FDA-approved test) Metastatic Colorectal Cancer (mCRC)*: In combination with FOLFOX for first-line treatment. ( 1 , 14.2 ) As monotherapy following disease progression after prior treatment with fluoropyrimidine, oxaliplatin, and irinotecan-containing chemotherapy. ( 1 , 14.1 ) KRAS G12C-mutated Metastatic Colorectal Cancer (mCRC)* In combination with sotorasib, for the treatment of adult patients with KRAS G12C- mutated mCRC, as determined by an FDA-approved test, who have received prior treatment …
Excerpt only. Read the full label for complete information.
About NDC 55513-954
- What is NDC 55513-954?
- 55513-954 is the product NDC for Vectibix (panitumumab), Panitumumab 100 mg/5mL solution, listed with the FDA by Amgen, Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vectibix (Panitumumab).
- What is the active ingredient?
- Panitumumab.
- Who is the labeler?
- Amgen, Inc, NDC labeler code 55513. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vectibix?
- 1 other product NDC are listed under this name. See all Vectibix NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Vectibix products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Vectibixpanitumumab | Panitumumab 400 mg/20mL | SolutionIntravenous | Amgen, Inc | 55513-956 | 55513-0956-0155513-0956-21 |
Other NDCs under BLA 125147
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vectibixpanitumumab | Panitumumab 400 mg/20mL | SolutionIntravenous | Amgen, Inc | 55513-956 |